The largest database of trusted experimental protocols

Pt link system

Manufactured by Agilent Technologies
Sourced in Denmark, United States

The PT Link system is a laboratory equipment product from Agilent Technologies. It is designed to provide a secure and reliable connection between analytical instruments and computing devices. The core function of the PT Link system is to enable the transfer of data and control commands between the instruments and the computing devices, facilitating the integration and automation of the analytical workflow.

Automatically generated - may contain errors

43 protocols using pt link system

1

Immunostaining Protocol for Tissue Sections

Check if the same lab product or an alternative is used in the 5 most similar protocols
Paraffin-embedded sections were stained using standard histology procedures. Immunostaining was carried out in 3 μm thick tissue sections that were deparaffinized and antigen retrieved using the PT Link system (Dako Diagnósticos) with Sodium Citrate Buffer (10 mM) adjusted to pH 6 or pH 9 depending on the immunohistochemical marker. Immunohistochemical staining was performed using the Dako Autostainer. The endogenous peroxidase was blocked and then sections were incubated for 30 min at room temperature with primary antibody: anti-CD3 and anti-CD4 (Dako) or anti-F4/80 (Serotec). After washing, slides were treated with the EnVision DuoFLEX Doublestain System using 3,3′-diaminobenzidine. For F4/80 staining, a rabbit anti-rat antibody was used as linker before EnVision treatment. Sections were counterstained with Carazzi's hematoxylin. The total number of positive stained cells was quantitated in 5 randomly chosen fields (200x) using Image-Pro Plus software. Data are expressed as positive stained area versus total analyzed area. Samples from each animal were examined in a blind manner. Negative controls were incubated with a nonspecific immunoglobulin of the same isotype as the primary antibody and without primary antibody.
+ Open protocol
+ Expand
2

Evaluating FH Expression in Breast Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
HEK 293 cells were transfected with FH full-length cDNA cloned in pcDNA3. Wild-type (WT) and FH-transfected 293 cell pellets were embedded in paraffin and sectioned. Tissue microarrays included biopsies from breast cancer patients (144 women) with ethical permission (ref. no. 445/2007). Tissue microarrays and controls were pre-treated using the PT-link system (Dako) with antigen retrieval at pH 6 and stained with goat anti-human FH antiserum (#A312; Quidel), mouse anti-human L20/3 (#sc-47686; Santa Cruz Biotechnology) and MRC-OX24 (ECACC Hybridoma Collection) for 30 min. The intensity of the staining in tumor cells was scored from 0 (negative) to 3 (high) by three researchers in a blinded manner. HER2 expression, hormone receptor status and Ki-67 were predetermined for the cohort.28-30
+ Open protocol
+ Expand
3

Histology and Immunohistochemistry Cryosectioning Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
For histology analysis, 5-μm OCT-embedded cryosections were subjected to Fast Green/Sirius Red staining. For immunohistochemistry analysis, cryosections were subjected to antigen retrieval in preheated sodium citrate buffer (pH 6.0, 98°C) for 10 min with the PT Link system (Dako). For cryo-sectioned tissues, deparaffinizing and antigen retrieval procedure were replaced by treatment of 1% Triton X-100 in PBS for 10 min at room temperature. After pre-incubation with 10% non-immune goat serum (Thermo Fisher Scientific) to prevent non-specific binding, tissue sections were incubated with primary antibodies at 4°C overnight and subsequently with appropriate Alexa-Fluor conjugated secondary antibodies (Thermo Fisher Scientific) for 1 h at room temperature. Finally, sections were stained with DAPI (Sigma) and mounted in VECTASHIELD antifade mounting medium (Vector Laboratories). Images were captured with Olympus BX41 (Olympus) or Zeiss Upright 780 confocal microscope (Zeiss). Section information was pre-coded and blind to procedure performers including embedding, sectioning, staining and imaging.
+ Open protocol
+ Expand
4

CD44v6 and Myc Co-Expression Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
CD44v6/Myc double-staining was performed on 5-µm-thick paraffin-embedded xenograft sections. Antigen retrieval was performed using the PT link system (Dako, Agilent technologies, Santa Clara, CA, USA) with a 10 mM sodium citrate solution (pH 6.0). Before primary antibody incubation, we performed two consecutive blocking steps: one for 5 min with a 3% H2O2 solution to inhibit endogenous peroxidase and the other for 20 min with 10% human serum to reduce unspecific signals. Thereafter, sections were exposed to antibodies specific for CD44v6 (2F10, R&D systems, Minneapolis, MN, USA) and Myc (rabbit polyclonal, CST, Danvers, MA, USA), diluted in antibody diluent solution (Dako, Agilent technologies, Santa Clara, CA, USA). The MACH 2 Double Stain 2 kit (Biocare Medical, Pacheco, CA, USA) was used to reveal primary antibodies, using DAB and Vulcan Fast Red chromogens for detection. Aqueous hematoxylin (Sigma-Aldrich, St. Louis, MO, USA) was used to counterstain cell nuclei.
CR-CSphCs exposed to vemurafenib, trastuzumab and BKM120 were fixed, permeabilized and incubated overnight at 4 °C with CD44v6 and Myc antibodies. Then, cells were stained with Alexa Fluor-488 goat anti-rabbit IgG and Rhodamine Red-x goat anti-mouse IgG1 (Life Technologies, Waltham, MA, USA) secondary antibodies. Toto-3 Iodide (Life Technologies, Waltham, MA, USA) was used to counterstain nuclei.
+ Open protocol
+ Expand
5

Breast Cancer Cohort Immunohistochemistry Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
The breast cancer cohort consists of 144 patients diagnosed with invasive breast cancer at Skåne University Hospital, Malmö, Sweden, between 2001 and 2002. The cohort and TMA have previously been described in detail19 (link)52 (link)53 (link). CXCL16 cytoplasmic expression was estimated in the malignant cells (intensity: 0=negative, 1= weak, 2=moderate, 3=strong intensity) and in the stromal fibroblasts (intensity 0=negative-weak, 1=strong intensity). Sections (4 μm thick) of the paraffin embedded tumours were mounted onto glass slides and deparaffinized, prior to antigen retrieval using the PT-link system (DAKO, Glostrup, Denmark) and staining in a Autostainer Plus (DAKO) with the EnVisionFlex High pH-kit (DAKO). All histological sections were counterstained with HE. All primary antibodies used for IHC are shown in Supplementary Table 4 (specificity; clone; dilution; company). Sirius Red staining was performed using in house methods. Cytospins were prepared from monocytes or non-enzymatic cell dissociation buffer-collected (Sigma Aldrich) M2 cultures that were air-dried.
+ Open protocol
+ Expand
6

Immunohistochemical Analysis of IgA1 in TMAs

Check if the same lab product or an alternative is used in the 5 most similar protocols
For immunohistochemistry (IHC) analysis, 4-μm TMA sections were automatically pretreated using the PT Link system (DAKO, Glostrup, Copenhagen, Denmark), and then stained in an Autostainer Plus (DAKO, Glostrup, Copenhagen, Denmark) with the primary antibody M4D8 anti-human IgA1 (dilution 1:3000) obtained from Margaret Goodall at The School of Immunity & Infection, Birmingham University (UK). The specificity of the antibody has been demonstrated previously [8] (link).
+ Open protocol
+ Expand
7

Immunohistochemical Analysis of BRG1 Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
For immunohistochemical analysis of Brahma-related gene 1 (BRG1) protein expression, 4-μm tissue microarray sections were automatically pretreated in the PT-link system (Dako, Glostrup, Denmark) and stained in an automated immunostainer (Autostainer Plus, Dako) using the Dako EnVision FLEX+ Detection System, Peroxidase/DAB, Rabbit/Mouse with the monoclonal anti-BRG1 antibody clone G-7 (Santa Cruz Biotechnology, Dallas, TX), diluted 1:25.
BRG1 was expressed in the tumor cell nuclei and present in the majority of tumor cells in positive cases. Therefore, only the intensity was annotated as 0 = negative, 1 = weak, 2 = moderate, and 3 = strong. Each tissue microarray core was evaluated separately, and the lowest and highest scores were denoted for each case. For the statistical analyses, a total score (0 to 6) was calculated from the sum of the lowest and highest scores. On the basis of visual inspection of Kaplan-Meier curves for the entire cohort and in strata according to morphology and adjuvant treatment, the total score was dichotomized into low (0 or 1) versus high (> 1) BRG1 staining.
+ Open protocol
+ Expand
8

Quantifying IGF1R Expression in Tumor Tissues

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immunohistochemical staining for IGF1R has been described previously (7 (link)). Briefly, TMA containing dual 1.0 mm cores from representative tumor regions from surgical specimens of formalin-fixed paraffin-embedded tissue blocks were constructed by a semi-automated tissue array device (Beeches instruments, Sun Prairie, WI, USA). The 4 µm thick sections were automatically deparaffinized and pretreated using the PT Link system (DAKO, Glostrup, Denmark). The sections were stained with anti-IGF1Rβ antibody (sc-713, Santa Cruz Biotechnology; dilution 1:150) using an Autostainer Plus from DAKO with EnVision FLEX high-pH kit according to the manufacturer’s instructions (DAKO, Glostrup, Denmark). Scoring was performed by two independent observers (Sofie Björner and Ann H. Rosendahl) and re-examination was performed in case of discrepancy (7.2%) until consensus was reached. A combined four level score of cytoplasmic and membrane staining intensity was used; negative, weak, moderate, strong. The highest score was applied in case of bilateral tumors (n = 15) and all scores came from the same tumor.
+ Open protocol
+ Expand
9

Immune Profiling in Melanoma Metastasis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Deparaffinization and antigen retrieval were performed in mouse melanoma lung metastasis using a PT-link system (Dako) and stained as previously described (13 (link)) The following antibodies were used for immune stainings: anti-iNOS, anti-CD206, anti-CD103, anti-Ki67, anti-granzyme B, anti-MPO, anti-CD86, anti-CD68, anti-MHC-II, anti-CD11b, anti-Ly6C, anti-Ly6G, and anti-PD-L1 all purchased from Abcam; anti-CD11c and anti-F4/80, purchased from BioLegend; anti-Foxp3 (Cell Signaling); anti-Arg1 (Bioss) and anti-CD8 (Dako) primary antibodies, anti-CD4 (BioLegend) and anti-CD25 (R&D Systems) followed by fluorescently labeled secondary antibodies. Images were acquired using an Axio Observer Light Microscope with the Apotome.2 (Zeiss). Metastatic melanoma lesions were gated by generating a region of interest (ROI), and threshold merge fluorescence was limited to ROI and calculated using the NIS-Elements Advanced Research 4.0 software (Nikon, Tokyo).
+ Open protocol
+ Expand
10

Immunohistochemical Analysis of RRM2 in Breast Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
4 μm thickness sections were cut from paraffin-embedded tissue microarray. Then deparaffinization was performed using xylene. After that, we rehydrated them with descending grade of alcohol followed by antigen retrieval in P-T link system from DAKO. Rabbit polyclonal primary antibody against RRM2 (NBP1–31661), obtained from NOVUS Biological, Centennial, Co 80,112 USA was used at a dilution rate of 1:50.
(DAB) was used as a chromogen, after that, hematoxylin was applied for counterstaining. Sections of breast cancer were used as a positive control for RRM2, while lymphoid follicles germinal centers were used as a positive control for Ki67. Cores fall rate was minimal and each case was presented by three cores. In case of falling cores, we considered the core that was remaining on the slides.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!